RBX2660

Unassigned

New Medicines

Clostridium difficile infection - prevention of recurrence

Information

Faecal Microbiota for Transplantation (FMT) product
Ferring
Ferring

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Immunomodulator. RBX2660 is a suspension in a ready-to-use enema formulation that contains live microbes designed to rebuild a healthy intestinal microbiome, known as a FMT (Faecal Microbiota for Transplantation) product.
C. difficile infection follows antibiotic therapy. In England in 2013-14, there were 13,361 reported cases [2].
Clostridium difficile infection - prevention of recurrence
Rectal

Evidence based evaluations

NIHR